New cancer registry aims to unlock secrets of ovarian and endometrial cancer treatment

NCT ID NCT05129969

Recruiting now Knowledge-focused Sponsor: iOMEDICO AG Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a large German registry that will follow nearly 2,000 people with advanced ovarian or endometrial cancer. Researchers will collect information on the treatments patients actually receive, how their disease responds, and their quality of life. The goal is to understand real-world care and outcomes, which could help improve future treatment strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could reveal which treatments work best in real-world settings, helping doctors make better decisions for future patients.
What could go wrong: This is an observational study, not a treatment trial. It collects data but does not test a new drug or therapy, so it won't directly cure or control cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma endometrial cancer endometrial carcinoma endometrium neoplasm ovarian cancer ovarian carcinoma ovarian neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA CARCINOMA, OVARIAN ENDOMETRIAL CANCER ENDOMETRIAL NEOPLASMS NEOPLASM, OVARIAN OVARIAN CANCER OVARY NEOPLASM

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Multiple sites all over Germany
RECRUITING

Multiple Locations, Germany

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.